UPClytics

Amgen Group

Operating company

HQ: United States

Total cases
19
Claimant-side
11
Respondent-side
8

Not counted above: 6 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View

Amgen Group has been party to 19 Unified Patent Court cases, 11 times as claimant and 8 times as respondent. The most recent on record is UPC CoA 153/2026 at the Court of Appeal. Its most recent decision on the merits was in UPC CoA 529/2024 at the Court of Appeal on 25 November 2025: patent upheld as granted.

Top opponents
  • Regeneron Pharmaceuticals Inc.9

More opponents

Top opponent firms
  • Carpmaels & Ransford11

More opposing firms

Top firms retained
  • Bardehle Pagenberg17

More of its firms

Start 14-day free trialEvery opponent and every firm acting for and against Amgen Group.Already a user? Sign in
Recent cases
Latest filings involving this group and its entities.
View all cases
  • 2026-09-15UPC CoA 153/2026File-access requestCarpmaels & Ransford LLP v Amgen Zdravila D.O.O.
  • 2025-12-23UPC CFI 2220/2025—Amgen Inc. v Sanofi-Aventis Deutschland GmbH
  • 2025-12-23UPC CFI 2221/2025—Amgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2025-07-14UPC CoA 641/2025WithdrawnSanofi Biotechnology SAS v Amgen Inc.
  • 2025-07-11UPC CoA 646/2025WithdrawnAmgen NV v Regeneron Pharmaceuticals Inc.
  • 2025-06-16UPC CFI 534/2025—Amgen S.A.S. v Sanofi Biotechnology SAS
  • 2025-02-28UPC CFI 195/2025WithdrawnSanofi Biotechnology SAS v Amgen Inc.
  • 2025-01-21UPC APP 3053/2025—Amgen GmbH v Alexion Pharmaceuticals, Inc.
  • 2025-01-21UPC APP 3214/2025File-access requestName not displayed for GDPR reasons. Represented by Sture RYGAARD v Sanofi-Aventis Deutschland GmbH
  • 2024-10-31UPC CFI 642/2024WithdrawnAMGEN Switzerland AG Vilniaus filialas v Alexion Pharmaceuticals, Inc.